JM
Therapeutic Areas
Orion Biotechnology Pipeline
| Drug | Indication | Phase |
|---|---|---|
| GPR75 Program | Obesity | Preclinical |
| GIPR Program | Metabolic / Obesity | Discovery |
| Amylin Program | Metabolic Disorders | Discovery |
Leadership Team at Orion Biotechnology
PT
Praveen Tyle, PhD
CEO
AK
Anatole Klepatsky, MBA
Chief Business Officer
JE
Jarret Engstrom, MBA/PMP
Executive Director, Project & Portfolio Management
OH
Oliver Hartley, PhD
Vice President, Drug Discovery
EH
Erik Heegard, MD/PhD
Medical Director